PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
PHXM was delisted on the 8th of March, 2024.
3 hedge funds and large institutions have $7.75M invested in PHAXIAM Therapeutics S.A.. American Depositary Shares in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
0.11% less ownership
Funds ownership: 4.19% → 4.08% (-0.11%)
25% less funds holding
Funds holding: 4 → 3 (-1)
32% less capital invested
Capital invested by funds: $11.4M → $7.75M (-$3.63M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$267K |
PHXM Hedge Fund Activity: Q3 2020 in Review
3 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) for Q3 2020, worth a combined $7.75M — down 32% from $11.4M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PHXM and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Phoenix Financial, exiting entirely with an estimated $267K sold.
- 3 institutional investors held PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) as of Q3 2020, down from 4 in Q2 2020.
- Funds reported $7.75M of PHAXIAM Therapeutics S.A.. American Depositary Shares stock for Q3 2020, down 32% quarter-over-quarter.
- 0 funds opened new PHAXIAM Therapeutics S.A.. American Depositary Shares positions in Q3 2020 and 1 closed out, a net change of -1 holder.
- The largest PHAXIAM Therapeutics S.A.. American Depositary Shares seller in Q3 2020 was Phoenix Financial, an estimated $267K sold.
Based on aggregated 13F filings for Q3 2020.